Business Wire

HCLTech Delivers Robust Performance in Q2FY26 with Revenue Growth of 4.6%

13.10.2025 20:08:00 CEST | Business Wire | Press release

Share

Deal wins at $2.6B; Advanced AI revenue crosses $100m

HCLTech, a leading global technology company, reported 4.6% YOY revenue growth in constant currency (CC) for the quarter ended September 30, 2025. USD revenue was at $3.6 billion, up 5.8% YoY. The company revised its Services Revenue growth (CC) guidance to 4%-5%, while retaining the overall revenue and margin guidance for FY26.

“We had a standout quarter on every front — marked by strong execution, growing demand for our AI-powered solutions and Advanced AI revenue exceeding $100 million this quarter. Our AI strategy is no longer just a vision; it is now a measurable driver of growth, differentiation and innovation. We are transitioning into an AI monetization phase. For the first time, our new bookings surpassed $2.5 billion, without reliance on any mega deal,” said C Vijayakumar, CEO & Managing Director, HCLTech.

HCLTech’s Services revenue grew by 5.5% YoY (CC). Digital revenue was up 15% YoY (CC) and now accounts for 42% of Services revenue. HCLSoftware’s Annual Recurring Revenue, at $1.06 billion, continues to grow.

Industry vertical growth was led by Technology and Services at 13.9% YoY growth (CC), followed by Telecommunications, Media, Publishing and Entertainment at 11.7% YoY (CC) and Financial Services at 11.4% YoY (CC). In terms of geographies, Europe grew at 7.6% YoY (CC) while the Rest of the World grew the fastest at 17.9% YoY (CC). The U.S. grew by 2.4%.

The company announced a dividend of ₹12 per share for the quarter, marking the 91st consecutive quarter of dividend payouts.

“HCLTech delivered strong INR revenue growth of 5.2% QoQ and 10.7% YoY in Q2 FY26. This superior revenue growth is accompanied by enhanced profitability and solid cash generation, with the last twelve months (LTM) FCF/NI ratio at 125%. We remain committed to improving our capital efficiency and are pleased to report LTM ROIC for the company is 38.6%, up 290 bps YoY and for Services business is 45.3%, up 180 bps YoY,” added Shiv Walia, Chief Financial Officer, HCLTech.

The company added 5,196 freshers during the quarter, taking the H1 fresher addition to 7,180. The LTM attrition moderated to 12.6%, among the lowest in the industry.

Key deal wins:

  • A leading US-based vacation ownership and resort management company expanded its partnership with HCLTech to modernize and transform its finance, accounting and mortgage operations with AI-powered digital solutions.
  • A US-based global consumer goods major selected HCLTech as its strategic partner to manage a large portfolio of enterprise applications and infrastructure across commercial, supply chain and corporate functions.
  • A Europe-based global retail major selected HCLTech to modernize its multi-channel application landscape. HCLTech’s solution will leverage AI Force to deliver a digital-first, future-ready platform that will enable seamless customer experiences across online and in-store channels.

Key AI deal wins:

  • A UK-based financial services major selected HCLTech to modernize its digital banking platforms and boost productivity. The solution uses AI Force to automate and augment the software development lifecycle, enabling faster time-to-market, improved platform resilience and superior digital experiences for its users.
  • A public sector transport authority in Australia selected HCLTech to enhance safety and compliance across waterways using a computer vision-based Physical AI solution. Built on HCLTech AI Foundry, the solution enables real-time detection of congestion, unsafe behavior and hazards at boat ramps, reducing response times and preventing accidents.
  • A US-based global manufacturer selected HCLTech AI Advisory services to build an Enterprise AI and Governance framework to scale AI initiatives with measurable ROI, regulatory compliance and Responsible AI principles.
  • A leading US-based telecom company selected HCLTech to launch an NVIDIA-powered Emerging Tech AI Lab. HCLTech is delivering advanced Cognitive Infrastructure Services, setting up a high-performance AI cluster and deploying state-of-the-art models such as Llama 405B, Maverick and Scout. This scalable, future-ready platform enables rapid AI experimentation and enterprise-wide AI adoption, reducing time-to-market and driving transformation.

HCLTech received dual recognition from TIME magazine: Highest-ranked India-headquartered technology company for the second consecutive year in the World’s Best Companies 2025 list and ranked among the top 15 in Professional Services in the World’s Most Sustainable Companies 2025 list.

About HCLTech

HCLTech is a global technology company, home to more than 226,600 people across 60 countries, delivering industry-leading capabilities centered around AI, digital, engineering, cloud and software, powered by a broad portfolio of technology services and products. We work with clients across all major verticals, providing industry solutions for Financial Services, Manufacturing, Life Sciences and Healthcare, High Tech, Semiconductor, Telecom and Media, Retail and CPG, Mobility and Public Services. Consolidated revenues as of 12 months ending September 2025 totaled $14.2 billion. To learn how we can supercharge progress for you, visit hcltech.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251013228975/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

FuzeBox AI Named Founding Co-Author of SPUR Coalition Technical Committee on Verifying AI Content Use5.10.2026 15:00:00 CEST | Press release

A new technical committee will define how publishers can independently confirm AI companies' reports of content use. FuzeBox AI has been named by the SPUR Coalition, an international nonprofit of 37 news and media organizations, as one of four founding co-authors of its Evidence Profile Technical Committee, adopted Sept. 2, 2026, to draft an evidence profile for SPUR's Content Telemetry standard: a way for publishers to verify AI usage reports without depending on the reporting company's cooperation. Under SPUR's current standard, AI companies self-report their content use. A company that skips reporting leaves no record, and publishers can't check what they do receive. On July 10, 2026, FuzeBox proposed its Verified Provenance Telemetry Standard (VPTS): publishers seed content with detectable markers, then verify their appearance in AI outputs via an auditable ledger, with no change to SPUR's standard. Within 48 hours, three organizations filed related proposals: ProRata on usage magn

Mary Kay Introduces the K-Beauty Texture Edit5.10.2026 14:02:00 CEST | Press release

Special-Edition Korea-Made Skin Care Collection Launches In 40 Markets, Available While Supplies Last Mary Kay Inc.,the iconic beauty giant announced today the launch of the K-Beauty Texture Edit, aspecial-edition skin care collection available while supplies last. The collection builds on the momentum of the company's largest consumer-facing global brand platform, Beauty Is More Beautiful Shared™ which launched in September. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261005600130/en/ Mary Kay's Special Edition K-Beauty Texture Edit is a trend-forward collection which includes three Korea-made products: the Mary Kay® Melt-In Cleansing Balm, Mary Kay® Snail Gel Face Patches and Mary Kay® Collagen Moisturizing Gel. (Image Credit: Mary Kay Inc.) Inspired by Korea's globally influential skin care and self-care philosophy designed to bring playful textures, innovative ingredients, and elevated beauty experiences, the K-Beauty

GE HealthCare to Acquire SOFIE Biosciences, Establishing a 'Final Mile' Footprint for PET Radiopharmaceutical Supply in the U.S.5.10.2026 14:00:00 CEST | Press release

Broadens GE HealthCare's footprint in the U.S. radiopharmaceutical industry, drives patient access to F18 labeled Positron Emission Tomography (PET) radiopharmaceuticals and enhances exposure to new high-growth areas Pharmaceutical Diagnostics (PDx) continues to partner with other established Contract Manufacturing Organizations (CMOs) to drive and expand patient access to its radiopharmaceutical portfolio, while SOFIE Biosciences continues to supply PET products from other leading radiopharmaceutical providers Provides U.S. rights to FAPI-74, a Phase III pipeline PET radiotracer with pan-cancer imaging potential, aiming to be among the first-to-launch in a large and fast-growing market1 GE HealthCare (Nasdaq: GEHC) today announced a definitive agreement to acquire SOFIE Biosciences, a leading U.S.-based CMO for PET radiopharmaceuticals, from Trilantic North America, for a purchase price of $945 million paid in cash. The transaction is expected to close in the first half of 2027, subje

Henkell Freixenet Strengthens Premium Dealcoholized Sparkling Wine Production with Solos' Patented Aroma Recovery System5.10.2026 13:24:00 CEST | Press release

The installation marks a significant step in the evolution of premium No/Low wines, where preserving aroma and sensory quality has become a defining industry priority. Henkell Freixenet is expanding its premium dealcoholized sparkling wine production capabilities through the deployment of Solos Technology's patented Aroma Recovery System (ARS) at its Wiesbaden production site, the Group’s expertise centre for alcohol-free production. The installation represents a significant investment in next-generation dealcoholized sparkling wine production, helping preserve the natural aroma and sensory identity of the original wines. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261005959301/en/ Fürst von Metternich Riesling Alcohol-free on the bottling line, one of the first products in Henkell Freixenet’s portfolio developed in collaboration with Solos Technology. The project combines Henkell Freixenet's longstanding winemaking exper

Croma-Pharma Expands Its Portfolio in Canada With saypha® lips Lidocaine and Exprecell™5.10.2026 13:12:00 CEST | Press release

Croma-Pharma continues to build its portfolio in Canada, adding saypha® lips Lidocaine, a hyaluronic acid filler for lip augmentation,1 and Exprecell™, a medical device for the preparation of autologous PRP | Fluid-PRF.2 Both are distributed by Renellence, Croma's partner in Canada since 2025. The two additions reflect Croma's broader approach: pairing established hyaluronic acid expertise with autologous, regenerative technologies. Together, they give practitioners options across both aesthetic and regenerative treatment categories, from a single trusted source. "With saypha® lips Lidocaine and Exprecell™, we're giving Canadian practitioners a wider set of tools for facial aesthetics and regenerative treatments, each held to the same standard of precision and safety," said Andreas Prinz, Chief Executive Officer of Croma-Pharma GmbH. Renellence has distributed Croma's Saypha® hyaluronic acid filler range in Canada since October 2025, alongside medical education and training for Canadia

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye